Table 1 Patients’ characteristics and afamin concentrations in the first-trimester cohort study
From: Is Afamin a novel biomarker for gestational diabetes mellitus? A pilot study
Parameter | Controls n = 51 | Gestational diabetes mellitus (GDM) n = 59 | p-value |
|---|---|---|---|
Maternal age (years) | |||
Mean (± standard deviation, SD) | 32.65 (4.79) | 34.36 (5.26) | 0.05 |
Median (Interquartile range, IQR) | 33.00 (29.25–36.00) | 36.00 (32.00–38.00) | |
Body-mass-index (kg/m2) | |||
Mean (± SD) | 24.76 (5.00) | 30.05 (8.02) | < 0.001 |
Median (IQR) | 24.00 (21.80–26.85) | 28.85 (24.40–34.30) | |
Afamin (mg/l) | |||
Mean (± SD) | 84.59 (17.75) | 115.46 (31.72) | < 0.001 |
Median (IQR) | 82.18 (68.68–100.57) | 117.13 (86.27–146.99) | |
Newborn weight (gram) | |||
Mean (± SD) | 3517 (453) | 3148 (730) | 0.03 |
Median (IQR) | 3490 (3270–3865) | 3320 (2868–3568) | |
Gestational age at parturition (days) | |||
Mean (± SD) | 276 (8) | 266 (21) | 0.02 |
Median (IQR) | 278 (272–282) | 273 (262–280) | |